Related Experiment Videos
Long-term reliability of endoscopic third ventriculostomy.
David Kadrian1, James van Gelder, Danielle Florida
1Department of Neurosurgery, Prince of Wales Hospital, Sydney, Australia.
Neurosurgery
|May 28, 2005
Summary
Endoscopic third ventriculostomy (ETV) shows high initial success for hydrocephalus treatment. However, long-term reliability is significantly influenced by patient age, with infants under six months experiencing poorer outcomes.
Area of Science:
- Neurosurgery
- Pediatric Neurosurgery
- Hydrocephalus Management
Background:
- Hydrocephalus is a complex neurological condition requiring effective treatment.
- Endoscopic third ventriculostomy (ETV) is a minimally invasive surgical option for hydrocephalus.
- Understanding the long-term outcomes and influencing factors of ETV is crucial for patient care.
Purpose of the Study:
- To evaluate the short-term success and long-term reliability of ETV in treating hydrocephalus.
- To investigate the impact of diagnosis, patient age, and prior shunt history on ETV outcomes.
Main Methods:
- Retrospective analysis of 203 consecutive patients undergoing ETV.
- Inclusion of patients with hydrocephalus from various causes, including aqueduct stenosis, myelomeningocele, tumors, and cysts.
- Long-term follow-up extending up to 22.6 years.
Main Results:
- Overall ETV success rate was 89%.
- Age was strongly associated with long-term reliability; infants <6 months had significantly lower reliability (31% at 1 year).
- No significant association found between reliability and diagnosis or previous shunt history.
Conclusions:
- Age is the sole statistically significant factor affecting the long-term reliability of ETV.
- ETV demonstrates poor long-term reliability in patients younger than six months.
- Further research may be needed to optimize ETV outcomes in young infants.